3SBio Inc. provided earnings guidance for the year ended 31 December 2021. For the year, the company expected that the net profit and the profit attributable to equity shareholders will record an increase ranging from 100% to 120% and 90% to 110%, respectively, compared with those for the corresponding period of last year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.31 HKD | 0.00% | +3.44% | -16.09% |
May. 29 | 3SBIO Unit to Cooperate on Development, Sale of Weight Management Injection | MT |
Apr. 22 | 3Sbio Inc. Announces Management Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.09% | 1.92B | |
+0.82% | 91.94B | |
-1.32% | 38.74B | |
-12.88% | 32.82B | |
+64.77% | 26.66B | |
-16.31% | 15.32B | |
-5.78% | 13.3B | |
-11.38% | 11.65B | |
+173.10% | 10.37B | |
-49.84% | 10.12B |
- Stock Market
- Equities
- 1530 Stock
- News 3SBio Inc.
- 3SBio Inc. Provides Earnings Guidance for the Year Ended 31 December 2021